Dong Xu

机构：Academy of Medical Sciences, Capital Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, National Clinical Research Center for Digestive Diseases, Zhejiang Cancer Hospital, Jiangxi Maternal and Child Health Hospital, Beijing Friendship Hospital, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0003-2243-1883

发表论文 84 篇 · 总被引 3772 次 · h-index 20

代表论文

• A Phase I/II Open-Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid Tumors (2019 · The Oncologist · 被引 48)
• Differentiating peritoneal tuberculosis and peritoneal carcinomatosis based on a machine learning model with CT: a multicentre study (2023 · Abdominal Radiology · 被引 18)
• The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining (2021 · BMC Cancer · 被引 15)
• Global and Chinese burden of non-alcoholic fatty liver disease in chronic liver disease: Findings from the Global Burden of Disease Study 2021 (2025 · Chinese Medical Journal · 被引 14)
• Chinese clinical practice guidelines for ultrasound-guided irreversible electroporation of liver cancer (version 2022) (2022 · Hepatobiliary & pancreatic diseases international · 被引 8)
• Clinical Characteristics and Prognosis of Patients With Antiphospholipid Antibodies Based on Cluster Analysis: An 8-Year Cohort Study (2021 · Research Square · 被引 5)